A product filing from a United States prediction market exchange arrives in two halves. One half says what the contract is, in the language a trader would recognise from the market page. The other half argues why listing it complies with federal law. Only the first half is reliably public. The second half can be segregated into an appendix and withheld, and that is lawful, ordinary, and done on almost every filing by at least one of the two largest venues.
The machinery underneath that choice is more interesting than the choice. Two Commodity Futures Trading Commission regulations can carry a confidentiality request on a product filing. They interlock, but they do not do the same thing, and which one a filing names decides whether anybody ever rules on the claim at all.
The regulation already says which half has to be public
The contents of a self certification are listed in Commission Regulation 40.2(a)(3). Subparagraph (ii) requires a copy of the rules setting out the contract's terms and conditions. Subparagraph (v) requires a concise explanation and analysis, complete with respect to the terms and conditions, the underlying commodity, and the product's compliance with the Commodity Exchange Act, including core principles. Subparagraph (iv) is the exchange's own certification that the product complies.
What must reach the public is answered one rule over. Commission Regulation 40.8(d) states that the terms and conditions of a product submitted under rules 40.2, 40.3, 40.5 and 40.6 shall be made publicly available at the time of submission, and that Commission staff will not consider confidential treatment requests for information required to be made public under the Act. Terms and conditions are on that list. The explanation and analysis is not.
So the asymmetry is not a loophole anyone found. It is the design. The document that tells you what you are buying is public by command. The document arguing the product is allowed to exist is public by default and withholdable on request, which is a weaker thing.
A confidentiality request has a named door, and it is not the FOIA rule
Regulation 40.2(a)(3)(vii) lists, as part of the submission itself, a request for confidential treatment, if appropriate, as permitted under rule 40.8. The subparagraph that creates the right to ask points at 40.8.
Read from the other side, the same signpost appears. Commission Regulation 145.9 is the general procedure by which anyone submitting material to the Commission can ask that it be shielded from release under the Freedom of Information Act. Its own scope paragraph, 145.9(b), says the section applies only where the Commission has not specified that an alternative procedure be used, and then sends the reader onward: see 40.8 for procedures to be used in connection with information required to be filed under parts 40 and 41. A product filing is exactly that.
The two are not rivals. Regulation 40.8(c)(1) says the form and content of the required justification shall be governed by 145.9, and 40.8(c)(5) says all confidentiality requests are subject to the process provided by 145.9. Rule 40.8 is the entry point and it borrows the machinery of 145.9. What it adds on the way in is the part that matters.
The entry rule wants the justification at the moment of filing
Under Regulation 40.8(c)(1), a detailed written justification of the confidential treatment request must be filed simultaneously with the request. Under 145.9(d)(1), by contrast, the submitter must specify the grounds but need not provide a detailed written justification unless required to do so under paragraph (e). Paragraph (e)(1) sets out when that happens: once the Commission's FOIA compliance staff determines that a FOIA request seeks the material, the submitter has ten business days to file the justification.
Same document, two different moments. On the 40.8 path it exists from day one. On the 145.9 path it may never need to be written, because the trigger is an outside request that may never arrive.
Under the FOIA rule alone, nothing is decided until an outsider asks
This is the sharpest difference and it is stated plainly in both texts. Regulation 145.9(d)(10) provides that, apart from summary rejection for procedural defects, no determination with respect to any request for confidential treatment will be made until the Commission receives a Freedom of Information Act request for the material. Regulation 40.8(c)(4), in the same breath, provides that Commission staff may make an initial determination on a confidentiality request without regard to whether the information has been sought under the Freedom of Information Act.
Put together: the proactive determination lives in 40.8 and nowhere else. A claim resting on 145.9 alone is not a claim that was examined and upheld. It is a claim that is waiting for a member of the public to care enough to file a FOIA request, and until then it holds by default.
Redaction on an exchange website is provisional by design
Regulation 40.2(a)(3)(vi) requires the exchange to certify that it posted a notice of the pending certification and a copy of the submission on its own website at the same time as filing. The same subparagraph allows information the entity seeks to keep confidential to be redacted from the website copy, and then adds a condition that is easy to read past: the redacted material must be republished consistent with any determination made under rule 40.8(c)(4).
The redaction is therefore conditional, and the condition is the determination that only the 40.8 route is built to produce without an outside prompt. A filing that frames its request solely under the FOIA procedure leaves that republication trigger attached to a decision which, by the terms of 145.9(d)(10), nobody is going to make.
All two hundred and two published filings name one rule and not the other
This is measurable, so we measured it. QCX LLC, trading as Polymarket US, publishes its product filings at an index on its exchange website. Read on 12 November 2026, that index held 202 filings. Every one of the 202 requests confidential treatment for an appendix. Every one of the 202 cites rule 145.9. None of the 202 cites rule 40.8.
The clause is boilerplate and barely a sentence long. In the amendment for the soccer athletic advancement contract filed on 1 July 2026, the compliance analysis is described as segregated as attachment B, for which the Exchange seeks confidential treatment pursuant to 17 C.F.R. section 145.9. The same construction carries across the set, whether the filing runs under rule 40.2 (179 of them), rule 40.6 (12), or cites both (11).
Across those 202 published copies, the words trade secret appear zero times, the phrase detailed written justification zero times, any reference to Freedom of Information Act Exemption 4 or to 5 U.S.C. 552(b) zero times, and rule 145.5 zero times. The published filings run from three to sixteen pages, with a median of four. One copy of the same material, the CAOC amendment of 20 May 2026, is also on the Commission's own site at the CFTC filings archive, and that version is likewise three pages with one mention of 145.9 and none of 40.8.
A caution on what that counts. Regulation 145.9(d)(2) sends the original of a confidentiality request to the Office of the General Counsel separately from the submission. The absence of a justification from a published copy is therefore not evidence that no justification reached the Commission. What the measurement does establish is what the public document says, and the public document is the whole of what a trader, a journalist or a rival venue can read.
The complete version of the same request runs three pages and anyone can read it
The reasoned version is not hypothetical. On 19 February 2026 KalshiEX LLC filed a standalone confidentiality request alongside a product certification, and it sits in the Commission's archive as a three page letter. Its header requests confidential treatment pursuant to 17 C.F.R. sections 40.8 and 145.9, naming both rules. It identifies itself as the detailed written justification. It names the ground, Exemption 4 of the Freedom of Information Act together with 145.9(d)(1)(ii) on trade secrets and confidential commercial information, and routes through rule 145.5. It states a duration, five years, which is what 145.9(d)(5) asks for. It confirms the cover sheet marking that 145.9(d)(4) requires. And it argues the standard on the authority of the Supreme Court of the United States in Food Marketing Institute v. Argus Leader Media, quoting the test that information is confidential where it is both customarily and actually treated as private by its owner and provided to the government under an assurance of privacy.
Note what that letter is. Regulation 145.9(d)(6) makes a confidentiality request a public document, and 145.9(e)(5) does the same for the detailed justification, with confidential affidavits allowed as a supplement. The reasoning behind a withholding is public by rule. Publishing it is not a concession. It is the baseline the rule assumed.
One venue segregates the analysis, the other prints it
The gap between those two approaches is visible at scale. KalshiEX publishes product certifications as individual documents, and its public market data listed 3,149 distinct certification documents behind 16,221 contract series when read on 12 November 2026. We sampled 299 of those documents at random and read them in full.
In 284 of the 299, the concise explanation and analysis is in the public document. In 291, there are separately marked confidential appendices carrying further material, typically the source agency and comparable detail. Thirteen of the sampled documents reproduce the confidentiality footer, which reads KalshiEX LLC, Confidential Treatment Under Regulations 40.8 and 145.9 Requested, again naming both rules. The sampled documents run three to twenty three pages, with a median of nine pages and a median of roughly 1,600 words. The certification for the mentions contracts is a twenty three page example.
Set that against a median of four pages on the other venue, where the analysis is the withheld appendix rather than the body. Both venues withhold something. They differ on whether the reasoning that the product complies is inside or outside the public document, and that is a choice each venue makes for itself, not a difference in the rules they file under.
The Division has already said what the public loses
On 24 July 2026 the Division of Market Oversight issued CFTC Letter No. 26-22, signed by acting director Duncan Hennes, on the self certification of event contract series. Its subject is a different practice, the broad template certification that bundles many permutations into one filing, and it should not be misread as being about confidentiality. But in explaining why that practice is a problem, the Division named the harm in terms that travel. Having described certifications that leave staff unable to evaluate the settlement methodology, data sources and core principles compliance of every permutation, the letter adds that the practice prevents market participants from accessing and evaluating such information.
That sentence is about information missing from a filing. Our argument, and it is ours rather than the Division's, is that the access side of the harm does not care why the information is unavailable. A participant who cannot read how settlement sources were assessed is in the same position whether the analysis was never written at the required level of detail or written and segregated into a confidential appendix. The letter also records that the Division had already asked for better filings in CFTC Letter No. 26-08 of 12 March 2026 and that many exchanges carried on regardless, which we covered when the same division sent the same filing advice twice in four months.
The foreseeable harm standard is narrower than a whole appendix
There is one more reason a blanket claim over an entire attachment sits awkwardly with the rules it invokes. Regulation 145.5 directs that the Commission withhold material in nonpublic records only where it reasonably foresees that disclosure would harm an interest protected by one of the listed exemptions, and requires the Commission to consider partial disclosure and to take reasonable steps to segregate and release material that is not exempt. Regulation 145.9(d)(8) puts the matching duty on the submitter, which bears the burden of specifying clearly and precisely what is covered, and provides that requests covering reasonably segregable material that is not exempt shall be summarily rejected.
A compliance analysis is not uniform. The portion explaining how a settlement source was selected may contain genuinely commercial material about a negotiated data relationship. The portion reciting why the contract satisfies a core principle usually restates public law against public terms. Treating the appendix as one indivisible secret asserts a foreseeable harm across both.
What a venue could publish without giving up what it is protecting
The initiative's second directive asks that settlement sources, conflicts of interest and the rest be stated in plain language on the surface where the trade happens. A product filing is not that surface, but it is where the venue's reasoning about those things is written down, and a venue willing to show that reasoning has an easier time with every later argument about whether it behaved well.
Four steps are available to any exchange without changing a word of the rules. Name both regulations in the request, as the 40.2(a)(3)(vii) signpost and the other venue's own footer already do, so that the claim lands on the path where staff can rule on it under 40.8(c)(4). State the ground and the duration in the public copy, which 145.9(d)(1) and (d)(5) require to be specified anyway. Segregate at paragraph level rather than attachment level, which is what 145.9(d)(8) asks for. And publish the detailed justification, which 145.9(e)(5) already makes a public document.
None of that discloses a data vendor's commercial terms. All of it makes the withholding legible, which is the difference between a market that looks closed and one that is simply keeping a narrow thing private. A venue prepared to go further can publish the compliance analysis itself, as the larger of the two does on most of its certifications, and a venue that wants its reasoning tested rather than merely filed can use the voluntary approval path instead, which we looked at when asking why no event contract has taken the approval route since 1995.
The asymmetry worth fixing is not that exchanges keep things private. It is that, as of 12 November 2026, the half of a filing arguing a product belongs on a regulated market is the half the public is least likely to read, and on one of the two largest venues the claim keeping it closed is phrased so that nobody will be asked to rule on it. Both are choices reversible by the filer alone, and the venue that reverses them first can point at a public record the next time somebody asks whether its reasoning was ever examined, as the player availability contracts showed when the team doctor stayed on the restricted list.